InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the detailed record of transactions filed by Kelly Timothy P, Dirigeant. Director active across 1 companies, notably Homology Medicines, Inc.. Cumulatively, 6 reports have been logged. Total volume traded: €116k. The latest transaction was filed on 1 March 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
3,630 shares
Common Stock
SEC:0000899243-22-001747·
3,630 shares
Common Stock
SEC:0000899243-22-001747:0·
€35054 shares@ €6.48340.6% of flow
Common Stock
SEC:0000899243-21-035330·
€57,5406,232 shares@ €9.232999.4% of flow
Common Stock
SEC:0000899243-21-035329·
€35054 shares@ €6.48340.3% of flow
Common Stock
SEC:0000899243-21-035330:0·
€57,5406,232 shares@ €9.232949.7% of flow
Common Stock
SEC:0000899243-21-035329:0·
6 of 6 declarations
About Kelly Timothy P
Kelly Timothy P is an Executive at Homology Medicines, Inc. While his specific role is noted as 'See Remarks', he contributes to the leadership and strategy of the company. His expertise is essential for guiding Homology in developing innovative therapeutic solutions.
